Outlook Therapeutics Files Definitive Proxy Statement
Ticker: OTLK · Form: DEF 14A · Filed: Feb 10, 2025 · CIK: 1649989
| Field | Detail |
|---|---|
| Company | Outlook Therapeutics, Inc. (OTLK) |
| Form Type | DEF 14A |
| Filed Date | Feb 10, 2025 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
TL;DR
Outlook Therapeutics filed its proxy statement for the March 11 meeting. Vote your shares!
AI Summary
Outlook Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) on February 10, 2025, for its annual meeting on March 11, 2025. The company, formerly known as Oncobiologics, Inc., is in the biological products sector and is based in Iselin, NJ. This filing is a standard procedural document for shareholder voting.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing for a public company's annual meeting and does not contain new material financial or operational information.
Key Players & Entities
- Outlook Therapeutics, Inc. (company) — Registrant
- Oncobiologics, Inc. (company) — Former Company Name
- 0001104659-25-010946 (filing_id) — Accession Number
- 20250210 (date) — Filing Date
- 20250311 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is a document filed with the SEC that provides shareholders with information about the matters to be voted on at a company's annual or special meeting of shareholders.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on February 10, 2025.
What is the date of the shareholder meeting Outlook Therapeutics is holding?
The shareholder meeting for Outlook Therapeutics is scheduled for March 11, 2025.
What was Outlook Therapeutics' former company name?
Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc.
Where is Outlook Therapeutics, Inc. located?
Outlook Therapeutics, Inc. is located at 111 S. Wood Avenue, Unit #100, Iselin, NJ 08830.
Filing Stats: 4,842 words · 19 min read · ~16 pages · Grade level 11.9 · Accepted 2025-02-10 16:16:57
Filing Documents
- tm252313d6_def14a.htm (DEF 14A) — 786KB
- lg_outlooktherapeutics-4clr.jpg (GRAPHIC) — 18KB
- bc_companytsr-4c.jpg (GRAPHIC) — 50KB
- bc_netincome-4c.jpg (GRAPHIC) — 49KB
- px_25outlkpxy01pg01-bw.jpg (GRAPHIC) — 367KB
- px_25outlkpxy01pg02-bw.jpg (GRAPHIC) — 304KB
- 0001104659-25-010946.txt ( ) — 3436KB
- otlk-20240930.xsd (EX-101.SCH) — 9KB
- otlk-20240930_def.xml (EX-101.DEF) — 9KB
- otlk-20240930_lab.xml (EX-101.LAB) — 32KB
- otlk-20240930_pre.xml (EX-101.PRE) — 10KB
- tm252313d6_def14a_htm.xml (XML) — 114KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 31 EXECUTIVE OFFICERS OF THE COMPANY 34
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 35 EQUITY COMPENSATION PLAN INFORMATION 45 PAY VERSUS PERFORMANCE 46 TRANSACTIONS WITH RELATED PERSONS 50 HOUSEHOLDING OF PROXY MATERIALS 52 OTHER MATTERS 53 APPENDIX A A-1 i TABLE OF CONTENTS OUTLOOK THERAPEUTICS, INC. 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830 (609) 619-3990 PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MARCH 11, 2025 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING Why am I receiving these materials? We have sent you this proxy statement, our annual report to stockholders for the fiscal year ended September 30, 2024 and the Proxy Card, or collectively, the Proxy Materials, because the Board of Directors, or the Board, of Outlook Therapeutics, Inc., sometimes referred to as the Company or Outlook Therapeutics, is soliciting your proxy to vote at the 2025 Annual Meeting of Stockholders, or the Annual Meeting, including any adjournment or postponement thereof. This proxy statement summarizes the information you will need to know to cast an informed vote at the Annual Meeting. You are invited to attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed Proxy Card, or follow the instructions below to submit your proxy over the telephone or through the internet. We intend to begin mailing these Proxy Materials on or about February 11, 2025 to all stockholders of record entitled to vote at the Annual Meeting. How do I attend the Annual Meeting? The Annual Meeting will be held on Tuesday, March 11, 2025, at 9:00 a.m. Central Time, at the offices of Cooley LLP, 110 N. Wacker Drive, Suite 4200, Chicago, Illinois 60606. Information on how to vote in person at the Annual Meeting is discussed below. Who can vote at the Annual Meeting? Only stockholders of record at the close of busi